IBDEI16Z ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19155,2)
 ;;=^5007484
 ;;^UTILITY(U,$J,358.3,19156,0)
 ;;=I69.390^^93^989^7
 ;;^UTILITY(U,$J,358.3,19156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19156,1,3,0)
 ;;=3^Apraxia following cerebral infarction
 ;;^UTILITY(U,$J,358.3,19156,1,4,0)
 ;;=4^I69.390
 ;;^UTILITY(U,$J,358.3,19156,2)
 ;;=^5007515
 ;;^UTILITY(U,$J,358.3,19157,0)
 ;;=I69.190^^93^989^8
 ;;^UTILITY(U,$J,358.3,19157,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19157,1,3,0)
 ;;=3^Apraxia following nontraumatic intracerebral hemorrhage
 ;;^UTILITY(U,$J,358.3,19157,1,4,0)
 ;;=4^I69.190
 ;;^UTILITY(U,$J,358.3,19157,2)
 ;;=^5007452
 ;;^UTILITY(U,$J,358.3,19158,0)
 ;;=I69.090^^93^989^9
 ;;^UTILITY(U,$J,358.3,19158,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19158,1,3,0)
 ;;=3^Apraxia following nontraumatic subarachnoid hemorrhage
 ;;^UTILITY(U,$J,358.3,19158,1,4,0)
 ;;=4^I69.090
 ;;^UTILITY(U,$J,358.3,19158,2)
 ;;=^5007420
 ;;^UTILITY(U,$J,358.3,19159,0)
 ;;=I69.890^^93^989^10
 ;;^UTILITY(U,$J,358.3,19159,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19159,1,3,0)
 ;;=3^Apraxia following other cerebrovascular disease
 ;;^UTILITY(U,$J,358.3,19159,1,4,0)
 ;;=4^I69.890
 ;;^UTILITY(U,$J,358.3,19159,2)
 ;;=^5007546
 ;;^UTILITY(U,$J,358.3,19160,0)
 ;;=I69.393^^93^989^12
 ;;^UTILITY(U,$J,358.3,19160,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19160,1,3,0)
 ;;=3^Ataxia following cerebral infarction
 ;;^UTILITY(U,$J,358.3,19160,1,4,0)
 ;;=4^I69.393
 ;;^UTILITY(U,$J,358.3,19160,2)
 ;;=^5007518
 ;;^UTILITY(U,$J,358.3,19161,0)
 ;;=I69.193^^93^989^13
 ;;^UTILITY(U,$J,358.3,19161,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19161,1,3,0)
 ;;=3^Ataxia following nontraumatic intracerebral hemorrhage
 ;;^UTILITY(U,$J,358.3,19161,1,4,0)
 ;;=4^I69.193
 ;;^UTILITY(U,$J,358.3,19161,2)
 ;;=^5007455
 ;;^UTILITY(U,$J,358.3,19162,0)
 ;;=I69.293^^93^989^16
 ;;^UTILITY(U,$J,358.3,19162,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19162,1,3,0)
 ;;=3^Ataxia following other nontraumatic intracranial hemorrhage
 ;;^UTILITY(U,$J,358.3,19162,1,4,0)
 ;;=4^I69.293
 ;;^UTILITY(U,$J,358.3,19162,2)
 ;;=^5007487
 ;;^UTILITY(U,$J,358.3,19163,0)
 ;;=I69.093^^93^989^14
 ;;^UTILITY(U,$J,358.3,19163,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19163,1,3,0)
 ;;=3^Ataxia following nontraumatic subarachnoid hemorrhage
 ;;^UTILITY(U,$J,358.3,19163,1,4,0)
 ;;=4^I69.093
 ;;^UTILITY(U,$J,358.3,19163,2)
 ;;=^5007423
 ;;^UTILITY(U,$J,358.3,19164,0)
 ;;=I69.893^^93^989^15
 ;;^UTILITY(U,$J,358.3,19164,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19164,1,3,0)
 ;;=3^Ataxia following other cerebrovascular disease
 ;;^UTILITY(U,$J,358.3,19164,1,4,0)
 ;;=4^I69.893
 ;;^UTILITY(U,$J,358.3,19164,2)
 ;;=^5007549
 ;;^UTILITY(U,$J,358.3,19165,0)
 ;;=I69.391^^93^989^17
 ;;^UTILITY(U,$J,358.3,19165,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19165,1,3,0)
 ;;=3^Dysphagia following cerebral infarction
 ;;^UTILITY(U,$J,358.3,19165,1,4,0)
 ;;=4^I69.391
 ;;^UTILITY(U,$J,358.3,19165,2)
 ;;=^5007516
 ;;^UTILITY(U,$J,358.3,19166,0)
 ;;=I69.191^^93^989^18
 ;;^UTILITY(U,$J,358.3,19166,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19166,1,3,0)
 ;;=3^Dysphagia following nontraumatic intracerebral hemorrhage
 ;;^UTILITY(U,$J,358.3,19166,1,4,0)
 ;;=4^I69.191
 ;;^UTILITY(U,$J,358.3,19166,2)
 ;;=^5007453
 ;;^UTILITY(U,$J,358.3,19167,0)
 ;;=I69.291^^93^989^20
 ;;^UTILITY(U,$J,358.3,19167,1,0)
 ;;=^358.31IA^4^2
